메뉴 건너뛰기




Volumn 81, Issue 6, 2013, Pages 1303-1307

Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; EPITHELIAL CELL ADHESION MOLECULE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

EID: 84878604752     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.10.041     Document Type: Article
Times cited : (23)

References (24)
  • 2
    • 33644675811 scopus 로고    scopus 로고
    • Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
    • H.I. Scher, and C.L. Sawyers Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis J Clin Oncol 23 2005 8253 8261
    • (2005) J Clin Oncol , vol.23 , pp. 8253-8261
    • Scher, H.I.1    Sawyers, C.L.2
  • 3
    • 41149166182 scopus 로고    scopus 로고
    • Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring
    • H. Lilja, D. Ulmert, and A.J. Vickers Prostate-specific antigen and prostate cancer: prediction, detection and monitoring Nature Rev Cancer 8 2008 268 278
    • (2008) Nature Rev Cancer , vol.8 , pp. 268-278
    • Lilja, H.1    Ulmert, D.2    Vickers, A.J.3
  • 4
    • 63249118690 scopus 로고    scopus 로고
    • Screening and prostate-cancer mortality in a randomized European study
    • F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
    • (2009) N Engl J Med , vol.360 , pp. 1320-1328
    • Schroder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 5
    • 22344450775 scopus 로고    scopus 로고
    • Prostate cancer clinical trial end points: "rECIST"ing a step backwards
    • H.I. Scher, M.J. Morris, and W.K. Kelly Prostate cancer clinical trial end points: "RECIST"ing a step backwards Clin Cancer Res 11 2005 5223 5232
    • (2005) Clin Cancer Res , vol.11 , pp. 5223-5232
    • Scher, H.I.1    Morris, M.J.2    Kelly, W.K.3
  • 6
    • 34248594553 scopus 로고    scopus 로고
    • Metastasis: Recent discoveries and novel treatment strategies
    • S.A. Eccles, and D.R. Welch Metastasis: recent discoveries and novel treatment strategies Lancet 369 2007 1742 1757
    • (2007) Lancet , vol.369 , pp. 1742-1757
    • Eccles, S.A.1    Welch, D.R.2
  • 7
    • 63049090100 scopus 로고    scopus 로고
    • Metastasis: From dissemination to organ-specific colonization
    • D.X. Nguyen, P.D. Bos, and J. Massague Metastasis: from dissemination to organ-specific colonization Nature Rev Cancer 9 2009 274 284
    • (2009) Nature Rev Cancer , vol.9 , pp. 274-284
    • Nguyen, D.X.1    Bos, P.D.2    Massague, J.3
  • 8
    • 58149165081 scopus 로고    scopus 로고
    • Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer
    • J.S. de Bono, H.I. Scher, and R.B. Montgomery Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer Clin Cancer Res 14 2008 6302 6309
    • (2008) Clin Cancer Res , vol.14 , pp. 6302-6309
    • De Bono, J.S.1    Scher, H.I.2    Montgomery, R.B.3
  • 9
    • 58949088650 scopus 로고    scopus 로고
    • Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): A single-centre experience
    • D. Olmos, H.T. Arkenau, and J.E. Ang Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience Ann Oncol 20 2009 27 33
    • (2009) Ann Oncol , vol.20 , pp. 27-33
    • Olmos, D.1    Arkenau, H.T.2    Ang, J.E.3
  • 10
    • 62849099048 scopus 로고    scopus 로고
    • Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: A reanalysis of IMMC38 trial data
    • H.I. Scher, X. Jia, and J.S. de Bono Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data Lancet Oncol 10 2009 233 239
    • (2009) Lancet Oncol , vol.10 , pp. 233-239
    • Scher, H.I.1    Jia, X.2    De Bono, J.S.3
  • 11
    • 66149098947 scopus 로고    scopus 로고
    • Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer
    • G. Attard, J.F. Swennenhuis, and D. Olmos Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer Cancer Res 69 2009 2912 2918
    • (2009) Cancer Res , vol.69 , pp. 2912-2918
    • Attard, G.1    Swennenhuis, J.F.2    Olmos, D.3
  • 12
    • 66749100105 scopus 로고    scopus 로고
    • Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
    • J.C. King, J. Xu, and J. Wongvipat Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis Nature Genet 41 2009 524 526
    • (2009) Nature Genet , vol.41 , pp. 524-526
    • King, J.C.1    Xu, J.2    Wongvipat, J.3
  • 13
    • 63449110302 scopus 로고    scopus 로고
    • Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer
    • M.A. Leversha, J. Han, and Z. Asgari Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer Clin Cancer Res 15 2009 2091 2097
    • (2009) Clin Cancer Res , vol.15 , pp. 2091-2097
    • Leversha, M.A.1    Han, J.2    Asgari, Z.3
  • 14
    • 27344451557 scopus 로고    scopus 로고
    • Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
    • S.A. Tomlins, D.R. Rhodes, and S. Perner Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648
    • (2005) Science , vol.310 , pp. 644-648
    • Tomlins, S.A.1    Rhodes, D.R.2    Perner, S.3
  • 15
    • 6044259206 scopus 로고    scopus 로고
    • Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
    • W.J. Allard, J. Matera, and M.C. Miller Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases Clin Cancer Res 10 2004 6897 6904
    • (2004) Clin Cancer Res , vol.10 , pp. 6897-6904
    • Allard, W.J.1    Matera, J.2    Miller, M.C.3
  • 16
    • 0029030591 scopus 로고
    • An immunological enrichment method for epithelial cells from peripheral blood
    • C. Griwatz, B. Brandt, and G. Assmann An immunological enrichment method for epithelial cells from peripheral blood J Immunol Methods 183 1995 251 265
    • (1995) J Immunol Methods , vol.183 , pp. 251-265
    • Griwatz, C.1    Brandt, B.2    Assmann, G.3
  • 17
    • 37549002543 scopus 로고    scopus 로고
    • Isolation of rare circulating tumour cells in cancer patients by microchip technology
    • S. Nagrath, L.V. Sequist, and S. Maheswaran Isolation of rare circulating tumour cells in cancer patients by microchip technology Nature 450 2007 1235 1239
    • (2007) Nature , vol.450 , pp. 1235-1239
    • Nagrath, S.1    Sequist, L.V.2    Maheswaran, S.3
  • 18
    • 33847402612 scopus 로고    scopus 로고
    • Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system
    • S. Riethdorf, H. Fritsche, and V. Muller Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system Clin Cancer Res 13 2007 920 928
    • (2007) Clin Cancer Res , vol.13 , pp. 920-928
    • Riethdorf, S.1    Fritsche, H.2    Muller, V.3
  • 19
    • 67049098048 scopus 로고    scopus 로고
    • The CTC-chip: An exciting new tool to detect circulating tumor cells in lung cancer patients
    • L.V. Sequist, S. Nagrath, and M. Toner The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients J Thorac Oncol 4 2009 281 283
    • (2009) J Thorac Oncol , vol.4 , pp. 281-283
    • Sequist, L.V.1    Nagrath, S.2    Toner, M.3
  • 20
    • 49249130844 scopus 로고    scopus 로고
    • Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
    • S.J. Cohen, C.J. Punt, and N. Iannotti Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer J Clin Oncol 26 2008 3213 3221
    • (2008) J Clin Oncol , vol.26 , pp. 3213-3221
    • Cohen, S.J.1    Punt, C.J.2    Iannotti, N.3
  • 21
    • 50949132840 scopus 로고    scopus 로고
    • Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer
    • T. Okegawa, K. Nutahara, and E. Higashihara Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer J Urol 180 2008 1342 1347
    • (2008) J Urol , vol.180 , pp. 1342-1347
    • Okegawa, T.1    Nutahara, K.2    Higashihara, E.3
  • 22
    • 37249006715 scopus 로고    scopus 로고
    • Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
    • D.C. Danila, G. Heller, and G.A. Gignac Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer Clin Cancer Res 13 2007 7053 7058
    • (2007) Clin Cancer Res , vol.13 , pp. 7053-7058
    • Danila, D.C.1    Heller, G.2    Gignac, G.A.3
  • 23
    • 80053007292 scopus 로고    scopus 로고
    • Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer
    • O.B. Goodman Jr., J.T. Symanowski, and A. Loudyi Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer Clin Genitourin Cancer 9 2011 31 38
    • (2011) Clin Genitourin Cancer , vol.9 , pp. 31-38
    • Goodman Jr., O.B.1    Symanowski, J.T.2    Loudyi, A.3
  • 24
    • 33947355892 scopus 로고    scopus 로고
    • The association between measures of progression and survival in castrate-metastatic prostate cancer
    • H.I. Scher, M. Warren, and G. Heller The association between measures of progression and survival in castrate-metastatic prostate cancer Clin Cancer Res 13 2007 1488 1492
    • (2007) Clin Cancer Res , vol.13 , pp. 1488-1492
    • Scher, H.I.1    Warren, M.2    Heller, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.